The current prices are delayed, login to your account for live prices
LOGIN
Create Alert
Watchlist

Laurus Labs

615.15
-7.85 (1.26%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Overview
News
Events
F&O

Performance

Open
626.70
Prev. Close
623.00
Volume
12,73,131
Total traded value
78.32 Cr
Upper Circuit
676.65
Lower Circuit
553.65

Analyst Estimates

40%
Buy
30%
Hold
30%
Sell
40%
Aggregated by Refinitiv from 10 Analysts

Fundamentals

Market Cap₹33,617Cr
ROE3.17%
P/E Ratio(TTM)168.03
EPS(TTM)3.71
P/B Ratio8.13
Dividend Yield0.13%
Industry P/E34.57
Book Value76.66
Debt to Equity0.67
Face Value2
Understand Fundamentals

Financials

Revenue
Profit
Net Worth
*All values are in Rs. Cr
1,1971,4581,1971,2281,424Dec '23Mar '24Jun '24Sep '24Dec '24
Quarterly
Yearly

About Laurus Labs

Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company offers integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. The Company operates through three segments: Laurus Generics, Laurus Synthesis, and Laurus Bio. The Laurus Generics segment comprises API and FDF-Development, manufacture and sale of APIs and advanced intermediates and oral solid formulations/FDF. Laurus Synthesis segment comprises key starting materials (KSM), intermediates and APIs for new chemical entities (NCEs). Laurus Bio segment comprises recombinant products, animal origin free products for safer and viral free bio manufacturing. The Company operates through two geographical segments: Revenue from customers within India-Domestic, and Revenue from customers outside India-Exports. The Company sell its APIs in 56 countries.;
Parent OrganisationLaurus Labs Limited
Managing DirectorNA
NSE SymbolLAURUSLABS

Shareholding Pattern

Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Retail And Others
34.08%
Promoters
27.62%
Foreign Institutions
25.56%
Mutual Funds
7.62%
Other Domestic Institutions
5.12%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Suven Pharmaceuticals
NA
(0.00%)
107.01
Piramal Pharma Ltd.
NA
(0.00%)
755.17
JB Chemicals & Pharmaceuticals
NA
(0.00%)
40.81
Wockhardt
NA
(0.00%)
-134.92
Groww
Want to invest in this stock?
Open a free Demat account in minutes to start investing in stocks.
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.9.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW